Bioprocessing White Papers
-
Harnessing Amino Acid Derivatives To Improve Monoclonal Antibodies
8/20/2023
Recent research in the fast-growing market of monoclonal antibodies (mAbs) identifies excipients that reduce viscosity of high-concentration formulation and improve stability across a wide concentration range.
-
COGs Process Economics For Autologous Cell Therapy
8/11/2023
Analyze the cost distribution over time for autologous CAR T therapy manufacturing using process economics and insights from scientists and R&D. Discover how cell therapy manufacturers can combat these costs.
-
The State Of Plastics Recycling In BioPharma
8/9/2023
Recycling plastics from biomanufacturing proves uniquely difficult due to circularity, quality, and infrastructure challenges. Nonetheless, change is underway. Learn how this change is being spearheaded by industry leaders.
-
Inspection Of Injectable Products For Visible Particulates
8/8/2023
Examine the risks posed by particulates, the potential sources and types of particulates, and approaches to detect and measure visible particulates in injectables.
-
Critical Considerations For Buffer Preparation
8/7/2023
Learn about the steps of buffer development, supply approach and strategy selection, choosing between in-house and outsourcing buffer activities, and other related buffer use topics.
-
Considerations And Strategies For Oligonucleotide Manufacturing Scale-Up
8/2/2023
To keep up with oligonucleotide demand, manufacturing needs to shift toward larger-scale processes, but this up-scaling process brings challenges that must be addressed.
-
Characterize T Cell Exhaustion And Hypofunctionality In Cancer
7/31/2023
Investigate what drives the hypofunctional state of T cells in ICB-nonresponsive cancers through the characterization of CD8+ T cell functionality in different tumor types.
-
Switching From Vials To PFS And Intravenous To Subcutaneous Formulations
7/25/2023
Learn about formulation development challenges for prefilled syringes as well as considerations for reducing the time it takes to launch safer, more convenient, and cost-effective products for the patient.
-
Solving Cost And Supply Challenges In Biopharma Downstream Processing
7/20/2023
In response to the growing demand for monoclonal antibodies, researchers are looking at different areas of the downstream process where they can improve efficiency and scalability.
-
De-risks Your Monoclonal Antibody Scale-Up Process
7/20/2023
Improve your mAb production by adopting a technology platform approach using a fluid handling system that can transition from development to your final production volume.